Involvement of B-Raf in Ras-induced Raf-1 activation

被引:23
作者
Mizutani, S [1 ]
Inouye, K [1 ]
Koide, H [1 ]
Kaziro, Y [1 ]
机构
[1] Tokyo Inst Technol, Fac Biosci & Biotechnol, Minato Ku, Yokohama, Kanagawa 2268501, Japan
关键词
Ras; Raf-1; B-Raf;
D O I
10.1016/S0014-5793(01)02992-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanism of Ras-induced Raf-1 activation is not full), understood. Previously, we identified a 400-kDa protein complex as a Ras-dependent Raf-1 activator. In this study, we identified B-Raf as a component of this complex. B-Raf was concentrated during the purification of the activator. linamunodepletion of B-Raf abolished the effect of the activator on Raf-1. Furthermore, B-Raf and Ras-activated Raf-I co-operatively, when co-transfected into human embryonic kidney 293 cells. On the other hand, Ras-dependent extracellular signal-regulated kinase/mitogen-activated protein kinase kinase stimulator (a complex of B-Raf and 14-3-3) failed to activate Raf-I in our cell-free system. These results suggest that B-Raf is an essential component of the Ras-dependent Raf-I activator. Oc 2001 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:295 / 298
页数:4
相关论文
共 50 条
[31]   B-RAF is a therapeutic target in melanoma [J].
Maria Karasarides ;
Antonio Chiloeches ;
Robert Hayward ;
Dan Niculescu-Duvaz ;
Ian Scanlon ;
Frank Friedlos ;
Lesley Ogilvie ;
Douglas Hedley ;
Jan Martin ;
Christopher J Marshall ;
Caroline J Springer ;
Richard Marais .
Oncogene, 2004, 23 :6292-6298
[32]   Cures with B-Raf inhibitors as single agents in metastatic B-Raf mutated melanoma: Curb your enthusiasm? [J].
Dasanu, Constantin A. .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (01) :205-206
[33]   A selective cellular screening assay for B-raf and c-raf kinases [J].
Ishii, Tsuyoshi ;
Sootome, Hiroshi ;
Yagi, Yukiko ;
Yamashita, Keizo ;
Noumi, Takato ;
Noro, Nobuhiro .
JOURNAL OF BIOMOLECULAR SCREENING, 2007, 12 (06) :818-827
[34]   An in silico study of the molecular basis of B-RAF activation and conformational stability [J].
Fratev, Filip F. ;
Jonsdottir, Svava Osk .
BMC STRUCTURAL BIOLOGY, 2009, 9
[35]   The mechanism of activation of monomeric B-Raf V600E [J].
Maloney, Ryan C. ;
Zhang, Mingzhen ;
Jang, Hyunbum ;
Nussinov, Ruth .
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 :3349-3363
[36]   RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer [J].
Pijnenborg, J. M. A. ;
Veen, G. C. Dam-de ;
Kisters, N. ;
Delvoux, B. ;
van Engeland, M. ;
Herman, J. G. ;
Groothuis, P. G. .
ANNALS OF ONCOLOGY, 2007, 18 (03) :491-497
[37]   Mammalian Raf-1 is activated by mutations that restore Raf signaling in Drosophila [J].
Cutler, RE ;
Morrison, DK .
EMBO JOURNAL, 1997, 16 (08) :1953-1960
[38]   Dual function of Ras in Raf activation [J].
Li, W ;
Melnick, M ;
Perrimon, N .
DEVELOPMENT, 1998, 125 (24) :4999-5008
[39]   RNA aptamers that specifically bind to the Ras-binding domain of Raf-1 [J].
Kimoto, M ;
Sakamoto, K ;
Shirouzu, M ;
Hirao, I ;
Yokoyama, S .
FEBS LETTERS, 1998, 441 (02) :322-326
[40]   VEMURAFENIB B-raf Kinase Inhibitor Oncolytic [J].
Puzanov, I. ;
Flaherty, K. T. ;
Sosman, J. A. ;
Grippo, J. F. ;
Su, F. ;
Nolop, K. ;
Lee, R. J. ;
Bollag, G. .
DRUGS OF THE FUTURE, 2011, 36 (03) :191-199